2003 | P-63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma | GYNECOLOGIC ONCOLOGY |
2015 | p-value approximations for spatial scan statistics using extreme value distributions | STATISTICS IN MEDICINE |
2022 | P50 implies adverse clinical outcomes in pediatric acute respiratory distress syndrome by reflecting extrapulmonary organ dysfunction
| SCIENTIFIC REPORTS |
2018 | Partial versus Radical Nephrectomy for T1-T2 Renal Cell Carcinoma in Patients with Chronic Kidney Disease Stage III: a Multiinstitutional Analysis of Kidney Function and Survival Rate
| Journal of Korean Medical Science |
2011 | Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. | ANTIVIRAL THERAPY |
2019 | Pathway-specific protein domains are predictive for human diseases
| PLOS COMPUTATIONAL BIOLOGY |
2016 | PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
| SCIENTIFIC REPORTS |
2021 | PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
| BMC CANCER |
2021 | Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial
| ESMO OPEN |
2017 | People with Spinal Cord Injury in Korea | AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION |
2022 | Perceived Risk of Re-Identification in OMOP-CDM Database: A Cross-Sectional Survey
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2012 | Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
| PLOS ONE |
2022 | Periodontal disease and cancer risk: A nationwide population-based cohort study
| FRONTIERS IN ONCOLOGY |
2020 | Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
| SCIENTIFIC REPORTS |
2020 | Personal Health Information Inference Using Machine Learning on RNA Expression Data from Patients With Cancer: Algorithm Validation Study
| JOURNAL OF MEDICAL INTERNET RESEARCH |
2023 | Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial | JOURNAL OF CLINICAL ONCOLOGY |
2020 | Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer
| CANCERS |
2015 | Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck | CLINICAL CANCER RESEARCH |
2022 | Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma | CLINICAL CANCER RESEARCH |
2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | RADIOTHERAPY AND ONCOLOGY |